Soleno Therapeutics, Inc. (SLNO)

Soleno Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,688	1,938	1,228	16	33	154
Market Cap Growth	135.84%	57.88%	7498.61%	-50.63%	-78.71%	17.03%
Enterprise Value	3,400	1,656	1,176	-3	5	98
Last Close Price	74.44	44.95	40.25	1.98	6.15	28.95
PB Ratio	15.55	7.91	7.79	1.56	1.84	3.37
P/TBV Ratio	16.10	8.13	8.25	-	6.35	4.96
Debt / Equity Ratio	0.23	0.22	0.00	0.02	0.03	0.00
Quick Ratio	18.43	15.55	14.75	2.00	2.66	5.71
Current Ratio	19.64	15.68	14.89	2.14	2.80	5.83
Return on Equity (ROE)	-105.54%	-87.35%	-46.45%	-171.05%	-97.60%	-81.46%
Return on Assets (ROA)	-52.40%	-45.06%	-23.33%	-50.58%	-40.11%	-38.71%
Return on Capital (ROIC)	-59.51%	-50.57%	-28.70%	-109.16%	-63.06%	-65.35%
Earnings Yield	-5.45%	-9.07%	-3.18%	-148.97%	-94.47%	-16.04%
FCF Yield	-2.46%	-3.58%	-2.03%	-128.71%	-84.94%	-16.42%
Buyback Yield / Dilution	-84.06%	-143.61%	-96.40%	-57.90%	-27.39%	-83.41%

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q